ORIONS Money Stocks

[Invest-in-America]

INAB vs. CNTB: INAB's drug addresses the RAREST form of Cancer, namely Leukemia, & one of the RAREST Human afflictions at large. On the other hand, CNTB's drug addresses Asthma, one of the World's most FREQUENT & COSTLY of all Human afflictions. Could the foregoing grossly-affect the eventual PRICE of the two Firms' STOCKS??? I think such might do that, thereby making CNTB's stock PRICE soar much higher than INAB's. However, such all depends upon the as-yet-UNKNOWN results of CNTB's trials. Indeed, more often than not, once Investors see those results, the stock in question COLLAPSES in price. (IMO)